Literature DB >> 6448870

Natural inhibitors of fibrinolysis.

D Collen.   

Abstract

Mesh:

Substances:

Year:  1980        PMID: 6448870      PMCID: PMC1347101     

Source DB:  PubMed          Journal:  J Clin Pathol Suppl (R Coll Pathol)        ISSN: 0144-0330


× No keyword cloud information.
  58 in total

1.  The lysis of artificially induced intravascular clots in man by intravenous infusions of streptokinase.

Authors:  A J JOHNSON; W R McCARTY
Journal:  J Clin Invest       Date:  1959-09       Impact factor: 14.808

2.  A plasminogen activator in spontaneously active human blood.

Authors:  S MULLERTZ
Journal:  Proc Soc Exp Biol Med       Date:  1953-02

3.  Kinetic properties of the primary inhibitor of plasmin from human plasma.

Authors:  U Christensen; I Clemmensen
Journal:  Biochem J       Date:  1977-05-01       Impact factor: 3.857

4.  On the kinetics of the reaction between human antiplasmin and plasmin.

Authors:  B Wiman; D Collen
Journal:  Eur J Biochem       Date:  1978-03-15

5.  Plasmatic and platelet anti-plasmins and anti-activators.

Authors:  G J Den Ottolander; B Leijnse; H M Cremer-Elfrink
Journal:  Thromb Diath Haemorrh       Date:  1967-12-31

6.  Synthetic inhibitors of fibrinolysis: in vitro and in vivo mode of action.

Authors:  S Okamoto; S Oshiba; H Mihara; U Okamoto
Journal:  Ann N Y Acad Sci       Date:  1968-06-28       Impact factor: 5.691

7.  The isolation and characterisation of a platelet-specific beta-globulin (beta-thromboglobulin) and the detection of antiurokinase and antiplasmin released from thrombin-aggregated washed human platelets.

Authors:  S Moore; D S Pepper; J D Cash
Journal:  Biochim Biophys Acta       Date:  1975-02-27

8.  Inhibition of urokinase by complex formation with human alpha1-antitrypsin.

Authors:  I Clemmensen; F Christensen
Journal:  Biochim Biophys Acta       Date:  1976-04-08

9.  Quantitative determination of the binding of epsilon-aminocaproic acid to native plasminogen.

Authors:  G Markus; J L DePasquale; F C Wissler
Journal:  J Biol Chem       Date:  1978-02-10       Impact factor: 5.157

10.  Inhibition of urokinase by complex formation with human antithrombin III in absence and presence of heparin.

Authors:  I Clemmensen
Journal:  Thromb Haemost       Date:  1978-06-30       Impact factor: 5.249

View more
  3 in total

1.  Pepsin fibrinolysis of artificial clots made from fibrinogen concentrate and bovine thrombin: the effect of pH and epsilon aminocaproic acid.

Authors:  G A Valenzuela; W D Spotnitz; D D Stone
Journal:  Surg Endosc       Date:  1989       Impact factor: 4.584

2.  Urokinase-type plasminogen activator and its receptor synergize to promote pathogenic proteolysis.

Authors:  H M Zhou; A Nichols; P Meda; J D Vassalli
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

3.  Plasmin inhibition by bacterial serpin: Implications in gum disease.

Authors:  Alicja Sochaj-Gregorczyk; Miroslaw Ksiazek; Irena Waligorska; Anna Straczek; Malgorzata Benedyk; Danuta Mizgalska; Ida B Thøgersen; Jan J Enghild; Jan Potempa
Journal:  FASEB J       Date:  2019-11-26       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.